Pyxis Oncology earnings were -$88.7M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest PYXS earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$25.3M, up 8.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PYXS reported annual earnings of -$79.6M, with 3% growth. The next PYXS earnings date is Nov 2, 2026.
On PYXS's earnings call on Aug 13, 2026, Pyxis Oncology (NASDAQ: PYXS) reported Q2 2026 earnings per share (EPS) of -$0.40, up 33.33% year over year. Total PYXS earnings for the quarter were -$25.35 million. In the same quarter last year, Pyxis Oncology's earnings per share (EPS) was -$0.30.
The next PYXS earnings call is Nov 2, 2026. Add PYXS to your watchlist to be reminded of Pyxis Oncology's next earnings date.
Is Pyxis Oncology profitable or losing money?
As of the last Pyxis Oncology earnings report, Pyxis Oncology is currently losing money. Pyxis Oncology's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$88.73 million, a 7.85% decrease year over year.
What was PYXS's earnings growth in the past year?
As of Pyxis Oncology's earnings date in Aug 13, 2026, Pyxis Oncology's earnings has grown year over year. PYXS earnings in the past year totalled -$88.73 million.
What are Pyxis Oncology's earnings expectations?
The current EPS estimate for Pyxis Oncology's earnings report in Nov 2, 2026 is -$0.27.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.